Tracked shipping to South Africa with premium packaging for just R199 

Ship to
South Africa
0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

Select your country

Americas

Europe

Rest of the world

portada Design and Analysis of Clinical Trials with Time-To-Event Endpoints
Type
Physical Book
Publisher
Language
English
Pages
616
Format
Paperback
ISBN13
9781138372665

Design and Analysis of Clinical Trials with Time-To-Event Endpoints

Peace, Karl E. (Author) · CRC Press · Paperback

Design and Analysis of Clinical Trials with Time-To-Event Endpoints - Peace, Karl E.

Cheaper New Book Imported to South Africa
Delivery: 20 Jul - 13 Aug Shipping: 12 to 14 business days.
R 1,499
Faster New Book Imported to South Africa
Delivery: 07 Jul - 29 Jul Shipping: 3 to 3 business days.
R 1,704
R 1,499

Synopsis "Design and Analysis of Clinical Trials with Time-To-Event Endpoints"

Using time-to-event analysis methodology requires careful definition of the event, censored observation, provision of adequate follow-up, number of events, and independence or "noninformativeness" of the censoring mechanisms relative to the event. Design and Analysis of Clinical Trials with Time-to-Event Endpoints provides a thorough presentation of the design, monitoring, analysis, and interpretation of clinical trials in which time-to-event is of critical interest.After reviewing time-to-event endpoint methodology, clinical trial issues, and the design and monitoring of clinical trials, the book focuses on inferential analysis methods, including parametric, semiparametric, categorical, and Bayesian methods; an alternative to the Cox model for small samples; and estimation and testing for change in hazard. It then presents descriptive and graphical methods useful in the analysis of time-to-event endpoints. The next several chapters explore a variety of clinical trials, from analgesic, antibiotic, and antiviral trials to cardiovascular and cancer prevention, prostate cancer, astrocytoma brain tumor, and chronic myelogonous leukemia trials. The book then covers areas of drug development, medical practice, and safety assessment. It concludes with the design and analysis of clinical trials of animals required by the FDA for new drug applications.Drawing on the expert contributors' experiences working in biomedical research and clinical drug development, this comprehensive resource covers an array of time-to-event methods and explores an assortment of real-world applications.

Customers reviews

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews